FindTrial
Sign In

Clinical efficacy of Donepezil on self care ability in patients with both diabetes and Alzheimer's disease

Clinical efficacy of Donepezil on self care ability in patients with both diabetes and Alzheimer's disease - AD-DM drug adherence study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001160
Enrollment
100
Registered
2008-05-19
Start date
2008-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes,Alzheimer&#39

Interventions

donepezil

Sponsors

The University of Tokyo Hospital, department of Geriatrics, departmrnt of diabetes and metabolism
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.65-85 years old 2.HbA1c 6.5%- 3.Having Alzheimer's disease by diagnostic criteria of DSM4-TR 4.MMSE score of 10-26 points 5.Cargivers to assure compliance 6.donepezil was not administered

Exclusion criteria

Exclusion criteria: Malignacy, sever heart failure, sever respiratory failure, sever hepatic failure, sever renal failure,immotible patient, sick sinus syndrome, AV block, gastrointestinal ulcer, asthema, COPD, Parkinson disease

Design outcomes

Primary

MeasureTime frame
drug adherence—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026